Ticker Symbol: EVOK
Evoke Pharma Inc
$0.98 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001403708
Company Profile
Evoke is a specialty pharmaceutical company focused primarily on the commercialization and development of drugs to treat GI disorders and diseases. The Company developed GIMOTI, a nasal spray formulation of metoclopramide, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adults.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 420 Stevens Ave Ste 370
Website: www.evokepharma.com
CEO: David Gonyer
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.37
Change:
-$0.02
(
-1.44%)
Days Range: $1.28 - $1.40
Beta: 0.23
52wk. High: $5.96
52wk. Low: $0.91
Ytd. Change -49.57%
50 Day Moving Average: $1.20
200 Day Moving Average: $1.56
Shares Outstanding: 3343070
Valuation
Market Cap: 458.0M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A